ClinicalTrials.Veeva

Menu

Prevalence of OSA and Diagnostic Accuracy of Type 3 Home Sleep Test in Difficult-to-treat Asthma

C

Chulalongkorn University

Status

Active, not recruiting

Conditions

OSA

Treatments

Device: home sleep test

Study type

Interventional

Funder types

Other

Identifiers

NCT06916858
0722/66

Details and patient eligibility

About

cross sectional cohort study enroll Patients diagnosed with difficult-to-treat asthma, aged over 18 years, and experiencing persistent symptoms as assessed by the Asthma Control Test (ACT) underwent type 1 in-laboratory polysomnography and type 3 HSAT within 1 month apart

Enrollment

37 estimated patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • difficult-to-treat asthma .
  • Patients aged 18 years or older

Exclusion criteria

  • Patients or volunteers unable to undergo type 1 and type 3 sleep studies,
  • Patients with symptoms compatible with other sleep disorders,
  • Patients with a history of or current stroke or transient ischemic attack and Other chronic respiratory diseases.
  • Patients diagnosed with obstructive sleep apnea

Trial design

Primary purpose

Screening

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

37 participants in 1 patient group

difficult to treat asthma
Other group
Description:
difficult to treat asthma run HST and PSG
Treatment:
Device: home sleep test

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems